Clinical Trial Update: Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of HTL0009936 evaluating cognition and BOLD fMRI signals in healthy elderly subjects. Sponsor: Nxera Pharma UK Limited; the study concerns Alzheim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• HTL0009936

Snippet

Sponsor: Nxera Pharma UK Limited | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED